Applied DNA Sciences Announces Completion of First Contract with Dr. Suwelack Skin and Healthcare AG and Appointment of Dr. Ste
July 25 2006 - 7:00AM
PR Newswire (US)
STONY BROOK, N.Y., July 25 /PRNewswire-FirstCall/ -- Applied DNA
Sciences, Inc. (OTC:APDN) (BULLETIN BOARD: APDN) , a DNA security
solutions company, announced today the completion of its first
contract with Dr. Suwelack Skin & Healthcare AG ("Suwelack").
Suwelack is recognized in Germany as the leader in the innovation,
development and manufacture of biomatrices for cosmeceutical and
healthcare applications. On May 9, 2006, Suwelack adopted APDN's
SigNature(TM) Program as one of many new initiatives that
complement its expansion into the North American market. APDN's
SigNature(TM) logo was printed with ink containing APDN's encrypted
botanical DNA technology, onto Suwelack's annual supply of
packaging and labels. Dr. James A. Hayward, CEO of APDN, stated:
"We believe that the completion of our first contract to supply DNA
embedded packaging and labels for Suwelack is a strong indication
that our DNA technology is ready-to-implement. The Suwelack project
took less than 3 months from start to finish, including
negotiations, design, technical specification, DNA embedment,
printing and authentication validations." APDN's forensic-based
technology can also help to enhance the power of existing security
technologies such as barcoding, RFIDs, smart cards, and optical
memory-based ID systems without adding significant cost or change
to operations and finished goods. APDN also today announced that
Dr. Stephane Shu Kin So has joined the scientific team at the APDN
laboratories in Stony Brook. Dr. Shu Kin So received his Ph.D. in
Molecular Genetics and Microbiology from State University of New
York in Stony Brook and has considerable experience in molecular
biology techniques, DNA cloning and genetic manipulations in
bacteria. He also received his Bachelor of Science Degree in
Biology from Binghamton University in Binghamton, New York. Dr.
Benjamin Liang, Strategic Technology Development Officer, stated:
"The addition of Dr. Shu Kin So is critical to our authentication
operations which are now fully functional. Our team provides
services to governments and corporations, and continues to refine
and shorten forensic authentication processes." About Applied DNA
Sciences, Inc. Applied DNA Sciences, Inc. (APDN) develops
proprietary DNA-embedded security solutions that use plant DNA to
verify authenticity and protect corporate and government agencies
from counterfeiting, fraud, piracy, product diversion, identity
theft and unauthorized intrusion into physical plant and databases.
Our common stock is registered under Section 12(g) of the
Securities Exchange Act of 1934 and is listed on the
Over-The-Counter Bulletin Board under the symbol "APDN". Contact:
MeiLin Wan, Applied DNA Sciences, Inc., 25 Health Sciences Drive,
Stony Brook, New York 11790; Tel: 631-444- 6370; Fax: 631-444.8848
http://www.adnas.com/. About Dr. Suwelack Skin & Healthcare AG
Dr. Suwelack Skin & Healthcare AG manufactures biomatrices for
skin and healthcare for cosmeceutical and medical applications.
Suwelack's patented technology uses a freeze-drying process to
gently extract water from natural raw materials, as a result of
which the raw materials are preserved in a highly pure form. By
using this technique the company is able to avoid using
preservative agents, chemical cross-linking agents and perfumes and
ensure the basis for skin compatibility. Contact: Nikolaus Uleer,
Dr. Suwelack Skin & Healthcare AG, Josef-Suwelack-Strasse,
48727 Billerbeck, Germany Tel: +49-2543-72-247 Fax: +49-2543-72-365
http://www.skin-healthcare.com/ The statements made by Applied DNA
Sciences, Inc. may be forward-looking in nature and are made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements describe
the Company's future plans, projections, strategies and
expectations, and are based on assumptions and involve a number of
risks and uncertainties, many of which are beyond the control of
Applied DNA Sciences, Inc. Actual results could differ materially
from those projected due to changes in interest rates, market
competition, changes in the local and national economies, and
various other factors detailed from time to time in Applied DNA
Sciences' SEC reports and filings, including our Form 10-KSB, filed
on January 12, 2006, our subsequent Quarterly Reports on Form
10-QSB, and our Current Reports on Form 8-K . The Company
undertakes no obligation to update publicly any forward- looking
statements to reflect new information, events or circumstances
after the date hereof to reflect the occurrence of unanticipated
events. DATASOURCE: Applied DNA Sciences, Inc. CONTACT: MeiLin Wan
of Applied DNA Sciences, Inc., +1-631-444-6370, fax:
+1-631-444-8848 Web site: http://www.adnas.com/
http://www.skin-healthcare.com/
Copyright